Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY32.45 CNY
Change Today -3.60 / -9.99%
Volume 1.4M
As of 3:00 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

lanzhou foci pharmaceutica-a (002644) Snapshot

Open
CNY33.00
Previous Close
CNY36.05
Day High
CNY33.00
Day Low
CNY32.45
52 Week High
06/11/15 - CNY65.50
52 Week Low
07/17/14 - CNY15.45
Market Cap
6.6B
Average Volume 10 Days
3.9M
EPS TTM
CNY0.20
Shares Outstanding
204.3M
EX-Date
06/24/15
P/E TM
166.4x
Dividend
CNY0.02
Dividend Yield
0.05%
Current Stock Chart for LANZHOU FOCI PHARMACEUTICA-A (002644)

Related News

No related news articles were found.

lanzhou foci pharmaceutica-a (002644) Related Businessweek News

No Related Businessweek News Found

lanzhou foci pharmaceutica-a (002644) Details

Lanzhou Foci Pharmaceutical Co., Ltd. manufacturers and distributes traditional Chinese medicines, western drugs, and raw herbs in China. It offers antibiotics; and products for gastrointestinal disorders and gynecological problems, as well as pediatric products. The company provides its products in various dosage forms, including pills, tablets, granules, capsules, concentrated decoctions, mixtures, oral liquids, syrups, and medicinal wines under the Min Shan and Foci brand names. It exports its products to approximately 27 countries and areas, which include the United States, the United Kingdom, Canada, Japan, Singapore, Indonesia, Thailand, Malaysia, Germany, the Netherlands, New Zealand, Australia, Russia, Ukraine, and Hong Kong. The company was founded in 1929 and is based in Lanzhou, China.

Founded in 1929

lanzhou foci pharmaceutica-a (002644) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lanzhou foci pharmaceutica-a (002644) Key Developments

Lanzhou Foci Pharmaceutical Co.,Ltd. Announces Cash Dividend for the Year 2014, Payable on June 24, 2015

Lanzhou Foci Pharmaceutical Co.,Ltd. announced cash dividend (tax included) of CNY 0.16000000 per 10 shares for the year 2014, payable on June 24, 2015. Record date is June 23, 2015 and ex-date is June 24, 2015.

Lanzhou Foci Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2014

Lanzhou Foci Pharmaceutical Co.,Ltd. announced at its AGM held on May 6, 2015, approved the cash dividend per 10 shares (tax included) was CNY 0.16000000.

Lanzhou Foci Pharmaceutical Co.,Ltd. to Report Q1, 2015 Results on Apr 24, 2015

Lanzhou Foci Pharmaceutical Co.,Ltd. announced that they will report Q1, 2015 results on Apr 24, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002644:CH CNY32.45 CNY -3.60

002644 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002644.
View Industry Companies
 

Industry Analysis

002644

Industry Average

Valuation 002644 Industry Range
Price/Earnings 100.0x
Price/Sales 17.2x
Price/Book 5.3x
Price/Cash Flow 207.1x
TEV/Sales 17.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANZHOU FOCI PHARMACEUTICA-A, please visit www.fczy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.